Literature DB >> 18499785

Quantitative cerebrovascular reserve measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease: initial experience with angiographic correlation.

K H Kang1, H S Kim, S Y Kim.   

Abstract

BACKGROUND AND
PURPOSE: CT perfusion is a much more readily accessible imaging method to assess cerebral hemodynamic status than single-photon emission CT. We prospectively assessed quantitative cerebrovascular reserve by using acetazolamide (ACZ)-challenged CT perfusion for evaluating hemodynamic impairment in ischemic adult Moyamoya disease and compared it with angiographic findings.
MATERIALS AND METHODS: Sixteen adult patients with ischemic Moyamoya disease and 12 age-matched normal control subjects underwent both ACZ-challenged CT perfusion and digital subtraction angiography. Normalized baseline hemodynamic parameters and their percent changes (PCs) were calculated in 56 hemispheres. We classified the degrees of distal carotid artery stenosis according to modified Suzuki stage and determined the presence of basal Moyamoya vessels (BMVs). The values of normalized parameters and their PCs were compared with angiographic findings.
RESULTS: Normalized baseline mean transit time (MTT) and PC of normalized cerebral blood flow (CBF) were significantly correlated with angiographic stages in all of the vascular territories; however, the correlation coefficient of the normalized baseline MTT was lower than that of the PC of CBF. In the external borderzone and the middle cerebral arterial territory, the hemispheres with extensive BMVs exhibited significantly lower PC values of CBF and significantly higher normalized baseline MTT values than those in hemispheres with diminished BMVs and in normal control subjects.
CONCLUSION: Among the hemodynamic parameters measured by ACZ-challenged CT perfusion, the PC of CBF correlated highly significantly with angiographic stage; however, the normalized baseline CT perfusion parameters showed weak or no significant correlation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499785      PMCID: PMC8119064          DOI: 10.3174/ajnr.A1129

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  21 in total

1.  Variability of the territories of the major cerebral arteries.

Authors:  A van der Zwan; B Hillen; C A Tulleken; M Dujovny; L Dragovic
Journal:  J Neurosurg       Date:  1992-12       Impact factor: 5.115

Review 2.  Cerebral perfusion CT: technique and clinical applications.

Authors:  Ellen G Hoeffner; Ian Case; Rajan Jain; Sachin K Gujar; Gaurang V Shah; John P Deveikis; Ruth C Carlos; B Gregory Thompson; Mark R Harrigan; Suresh K Mukherji
Journal:  Radiology       Date:  2004-04-29       Impact factor: 11.105

Review 3.  Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models.

Authors:  M Wintermark; P Maeder; J P Thiran; P Schnyder; R Meuli
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

4.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

5.  The relationship between cerebral infarction and angiographic characteristics in childhood moyamoya disease.

Authors:  S Mugikura; S Takahashi; S Higano; R Shirane; N Kurihara; S Furuta; M Ezura; A Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  1999-02       Impact factor: 3.825

6.  Moyamoya disease: evaluation with diffusion-weighted and perfusion echo-planar MR imaging.

Authors:  I Yamada; Y Himeno; T Nagaoka; H Akimoto; Y Matsushima; T Kuroiwa; H Shibuya
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

Review 7.  Cerebral hemodynamics in ischemic cerebrovascular disease.

Authors:  W J Powers
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

8.  SPECT and MRI evaluations of the posterior circulation in moyamoya disease.

Authors:  I Yamada; Y Murata; I Umehara; S Suzuki; Y Matsushima
Journal:  J Nucl Med       Date:  1996-10       Impact factor: 10.057

9.  Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.

Authors:  Colin P Derdeyn; Tom O Videen; Kent D Yundt; Susanne M Fritsch; David A Carpenter; Robert L Grubb; William J Powers
Journal:  Brain       Date:  2002-03       Impact factor: 13.501

10.  Reproducibility of quantitative CT brain perfusion measurements in patients with symptomatic unilateral carotid artery stenosis.

Authors:  A Waaijer; I C van der Schaaf; B K Velthuis; M Quist; M J P van Osch; E P A Vonken; M S van Leeuwen; M Prokop
Journal:  AJNR Am J Neuroradiol       Date:  2007-05       Impact factor: 3.825

View more
  15 in total

Review 1.  Quantitative hemodynamic studies in moyamoya disease: a review.

Authors:  Marco Lee; Greg Zaharchuk; Raphael Guzman; Achal Achrol; Teresa Bell-Stephens; Gary K Steinberg
Journal:  Neurosurg Focus       Date:  2009-04       Impact factor: 4.047

2.  Cerebral blood flow measurement in neurosurgery.

Authors:  David Mette; Rhonda Strunk; Mario Zuccarello
Journal:  Transl Stroke Res       Date:  2011-02-12       Impact factor: 6.829

3.  Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.

Authors:  C Heyn; J Poublanc; A Crawley; D Mandell; J S Han; M Tymianski; K terBrugge; J A Fisher; D J Mikulis
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

4.  Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.

Authors:  Robert Goetti; Ruth O'Gorman; Nadia Khan; Christian J Kellenberger; Ianina Scheer
Journal:  Neuroradiology       Date:  2013-02-13       Impact factor: 2.804

5.  Improvement of image quality and radiation dose of CT perfusion of the brain by means of low-tube voltage (70 KV).

Authors:  Zhen-lin Li; Hang Li; Kai Zhang; Wang-jiang Li; Xian Chen; Bin Wu; Bin Song
Journal:  Eur Radiol       Date:  2014-06-04       Impact factor: 5.315

6.  Patient selection for revascularization procedures in adult Moyamoya disease based on dynamic perfusion computerized tomography with acetazolamide challenge (PCTA).

Authors:  Norberto Andaluz; Ondrej Choutka; Achala Vagal; Rhonda Strunk; Mario Zuccarello
Journal:  Neurosurg Rev       Date:  2010-02-06       Impact factor: 3.042

Review 7.  Consensus statement on current and emerging methods for the diagnosis and evaluation of cerebrovascular disease.

Authors:  Manus J Donahue; Eric Achten; Petrice M Cogswell; Frank-Erik De Leeuw; Colin P Derdeyn; Rick M Dijkhuizen; Audrey P Fan; Rashid Ghaznawi; Jeremy J Heit; M Arfan Ikram; Peter Jezzard; Lori C Jordan; Eric Jouvent; Linda Knutsson; Richard Leigh; David S Liebeskind; Weili Lin; Thomas W Okell; Adnan I Qureshi; Charlotte J Stagg; Matthias Jp van Osch; Peter Cm van Zijl; Jennifer M Watchmaker; Max Wintermark; Ona Wu; Greg Zaharchuk; Jinyuan Zhou; Jeroen Hendrikse
Journal:  J Cereb Blood Flow Metab       Date:  2017-08-17       Impact factor: 6.200

8.  Multi-delay arterial spin labeling perfusion MRI in moyamoya disease--comparison with CT perfusion imaging.

Authors:  Rui Wang; Songlin Yu; Jeffry R Alger; Zhentao Zuo; Juan Chen; Rong Wang; Jing An; Bo Wang; Jizong Zhao; Rong Xue; Danny J J Wang
Journal:  Eur Radiol       Date:  2014-02-21       Impact factor: 5.315

9.  Prediction of cerebral hyperperfusion syndrome after carotid artery stenting by CT perfusion imaging with acetazolamide challenge.

Authors:  Tomohide Yoshie; Toshihiro Ueda; Tatsuro Takada; Shinji Nogoshi; Takayuki Fukano; Yasuhiro Hasegawa
Journal:  Neuroradiology       Date:  2015-12-02       Impact factor: 2.804

10.  Ischemic and hemorrhagic moyamoya disease in adults: CT findings.

Authors:  Anming Xie; Li Luo; Yaojun Ding; Gongjie Li
Journal:  Int J Clin Exp Med       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.